Consensus IRADIMED CORPORATION

Equities

IRMD

US46266A1097

Market Closed - Nasdaq Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
43.94 ^USD	-0.05%		+2.42%	-7.44%

06-07	IRadimed to Begin Trading on the Nasdaq Global Market	MT
05-02	Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024

Evolution of the average Target Price on IRADIMED CORPORATION

Price target over the last 5 years

History of analyst recommendation changes

9ef07c20c3ad27f6.j2lSWhieEtxlmoX1fim3ikCp9JurIpP1MNhTli6KiyM.7go3Llb8a7Iq9869S2788zfTsuziEcGfcYoS80PzunD2JSYSWc1Tli_z7g~52743e7f0a8e41d9f402cc29193c7297

Analyst Recommendations on IRADIMED CORPORATION

Roth Capital Adjusts IRadimed's Price Target to $42 From $36, Maintains Buy Rating	02/11/21	MT
IRADIMED : Roth Capital Adjusts iRadimed's Price Target to $36 from $32, Keeps Buy Rating	02/08/21	MT